登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《MedRxiv，5月16日，Loss of Taste and Smell as Distinguishing Symptoms of COVID-19》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-05-17

  • Loss of Taste and Smell as Distinguishing Symptoms of COVID-19

    View ORCID ProfilePatrick Dawson, Elizabeth M. Rabold, Rebecca L. Laws, Erin E. Conners, Radhika Gharpure, Sherry Yin, Sean Buono, Trivikram Dasu, Sanjib Bhattacharyya, Ryan P. Westergaard, Ian W. Pray, Dongni Ye, Scott A. Nabity, Jacqueline E. Tate, Hannah L. Kirking

    doi: https://doi.org/10.1101/2020.05.13.20101006

    Abstract

    Olfactory and taste dysfunctions have emerged as symptoms of COVID-19. Among individuals with COVID-19 enrolled in a household study, loss of taste and/or smell was the fourth most commonly reported symptom (26/42; 62%), and among household contacts, it had the highest positive predictive value (83%; 95% CI: 55-95%) for COVID-19. These findings support consideration of loss of taste and/or smell in possible case identification and testing prioritization for COVID-19.

    *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.

  • 原文来源：https://www.medrxiv.org/content/10.1101/2020.05.13.20101006v1
36浏览量
原文链接
相关报告

  • 《MedRxiv，5月24日，（第3版更新）More than smell. COVID-19 is associated with severe impairment of smell, taste, and chemesthesis》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-05-25
    • More than smell. COVID-19 is associated with severe impairment of smell, taste, and chemesthesis Abstract Recent anecdotal and scientific reports have provided evidence of a link between COVID-19 and chemosensory impairments such as anosmia. However, these reports have downplayed or failed to distinguish potential effects on taste, ignored chemesthesis, generally lacked quantitative measurements, were mostly restricted to data from single countries. Here, we report the development, implementation and initial results of a multi-lingual, international questionnaire to assess self-reported quantity and quality of perception in three distinct chemosensory modalities (smell, taste, and chemesthesis) before and during COVID-19. In the first 11 days after questionnaire launch, 4039 participants (2913 women, 1118 men, 8 other, ages 19-79) reported a COVID-19 diagnosis either via laboratory tests or clinical assessment. Importantly, smell, taste and chemesthetic function were each significantly reduced compared to their status before the disease. Difference scores (maximum possible change+/-100) revealed a mean reduction of smell (-79.7+/- 28.7, mean+/- SD), taste (-69.0+/- 32.6), and chemesthetic (-37.3+/- 36.2) function during COVID-19. Qualitative changes in olfactory ability (parosmia and phantosmia) were relatively rare and correlated with smell loss. Importantly, perceived nasal obstruction did not account for smell loss. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    80浏览量
    原文链接

  • 《MedRxiv，5月3日，Predictive value of sudden olfactory loss in the diagnosis of COVID-19》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-05-04
    • Predictive value of sudden olfactory loss in the diagnosis of COVID-19 Antje Haehner, Julia Draf, Sarah Draeger, Katja de With, Thomas Hummel doi: https://doi.org/10.1101/2020.04.27.20081356 Abstract Introduction: Recent reports suggest that sudden smell loss might be a symptom of SARS-CoV-2 infection. The aim of this study was to investigate the frequency of olfactory loss in an out-patient population who presented to a coronavirus testing center during a 2-week period and to evaluate the diagnostic value of the symptom sudden smell loss for screening procedures. Methods: In this cross-sectional controlled cohort study, 500 patients who presented with symptoms of a common cold to a corona testing center and fulfilled corona testing criteria, completed a standardized diagnostic questionnaire which included the patients main symptoms, time course and an additional self-assessment of the patients current smell, taste function and nasal breathing compared to the level before onset of symptoms. Results: Out of the 500 patients, 69 presented with olfactory loss. Twenty-two of them subsequently tested positive for SARS-CoV-2. Only twelve out of the patients without olfactory loss tested positive, resulting in a frequency of 64.7% for the symptom sudden smell loss in COVID-19 patients. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    30浏览量
    原文链接